126 related articles for article (PubMed ID: 35659173)
21. The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue.
Li X; Chen Z; Li Z; Huang G; Lin J; Wei Q; Liang J; Li W
BMC Urol; 2020 Jun; 20(1):61. PubMed ID: 32487245
[TBL] [Abstract][Full Text] [Related]
22. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
23. Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor.
Chesney J; Clark J; Lanceta L; Trent JO; Telang S
Oncotarget; 2015 Jul; 6(20):18001-11. PubMed ID: 26221874
[TBL] [Abstract][Full Text] [Related]
24. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
[No Abstract] [Full Text] [Related]
25. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases.
Yalcin A; Clem BF; Simmons A; Lane A; Nelson K; Clem AL; Brock E; Siow D; Wattenberg B; Telang S; Chesney J
J Biol Chem; 2009 Sep; 284(36):24223-32. PubMed ID: 19473963
[TBL] [Abstract][Full Text] [Related]
26. PFKFB4 interacts with ICMT and activates RAS/AKT signaling-dependent cell migration in melanoma.
Sittewelle M; Kappès V; Zhou C; Lécuyer D; Monsoro-Burq AH
Life Sci Alliance; 2022 Aug; 5(12):. PubMed ID: 35914811
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis.
Lu C; Qiao P; Fu R; Wang Y; Lu J; Ling X; Liu L; Sun Y; Ren C; Yu Z
Cell Death Dis; 2022 Sep; 13(9):790. PubMed ID: 36109523
[TBL] [Abstract][Full Text] [Related]
28. PFKFB4 controls embryonic patterning via Akt signalling independently of glycolysis.
Pegoraro C; Figueiredo AL; Maczkowiak F; Pouponnot C; Eychène A; Monsoro-Burq AH
Nat Commun; 2015 Jan; 6():5953. PubMed ID: 25601028
[TBL] [Abstract][Full Text] [Related]
29. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
Kam CS; Ho DW; Ming VS; Tian L; Sze KM; Zhang VX; Tsui YM; Husain A; Lee JM; Wong CC; Chan AC; Cheung TT; Chan LK; Ng IO
Cell Mol Gastroenterol Hepatol; 2023; 15(6):1325-1350. PubMed ID: 36806581
[TBL] [Abstract][Full Text] [Related]
30. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
[TBL] [Abstract][Full Text] [Related]
31. Sertoli-secreted FGF-2 induces PFKFB4 isozyme expression in mouse spermatogenic cells by activation of the MEK/ERK/CREB pathway.
Gómez M; Manzano A; Figueras A; Viñals F; Ventura F; Rosa JL; Bartrons R; Navarro-Sabaté À
Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E695-707. PubMed ID: 22811469
[TBL] [Abstract][Full Text] [Related]
32. Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines.
Minchenko OH; Opentanova IL; Ogura T; Minchenko DO; Komisarenko SV; Caro J; Esumi H
Acta Biochim Pol; 2005; 52(4):881-8. PubMed ID: 16025159
[TBL] [Abstract][Full Text] [Related]
33. Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression.
Hsin MC; Hsieh YH; Hsiao YH; Chen PN; Wang PH; Yang SF
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803236
[TBL] [Abstract][Full Text] [Related]
34. PFKFB4 control of AKT signaling is essential for premigratory and migratory neural crest formation.
Figueiredo AL; Maczkowiak F; Borday C; Pla P; Sittewelle M; Pegoraro C; Monsoro-Burq AH
Development; 2017 Nov; 144(22):4183-4194. PubMed ID: 29038306
[TBL] [Abstract][Full Text] [Related]
35. PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer.
Lu H; Chen S; You Z; Xie C; Huang S; Hu X
Dev Growth Differ; 2020 Feb; 62(2):129-138. PubMed ID: 31912488
[TBL] [Abstract][Full Text] [Related]
36. Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells.
Taylor C; Mannion D; Miranda F; Karaminejadranjbar M; Herrero-Gonzalez S; Hellner K; Zheng Y; Bartholomeusz G; Bast RC; Ahmed AA
Oncotarget; 2017 Mar; 8(11):17960-17980. PubMed ID: 28152500
[TBL] [Abstract][Full Text] [Related]
37. Cancer cell metabolism: there is no ROS for the weary.
Dang CV
Cancer Discov; 2012 Apr; 2(4):304-7. PubMed ID: 22576206
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
39. Expression of Alternative Splice Variants of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase-4 in Normoxic and Hypoxic Melanoma Cells.
Trojan SE; Dudzik P; Totoń-Żurańska J; Laidler P; Kocemba-Pilarczyk KA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445551
[TBL] [Abstract][Full Text] [Related]
40. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma.
Marampon F; Bossi G; Ciccarelli C; Di Rocco A; Sacchi A; Pestell RG; Zani BM
Mol Cancer Ther; 2009 Mar; 8(3):543-51. PubMed ID: 19258428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
